SCHEMBL26327735

SCHEMBL26327735

CC1(C)/C(=C2/C(=O)Nc3ccc(S(C)(=O)=O)cc32)Nc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 3/20 0.41
▸ PDK2 Q15119 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MGAT2 Q10469 2/20 0.37
▸ STK10 O94804 1/20 0.36
▸ SLK Q9H2G2 1/20 0.36
▸ ROS1 P08922 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ ACVR1 Q04771 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ MAOA P21397 2/20 0.36
▸ MAOB P27338 1/20 0.36
▸ CASP3 P42574 3/20 0.35
▸ CAPN9 O14815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15453587 0.89 CA1 (0.53) PTGS2PDK2PDK4CA12CA1
SCHEMBL15453585 0.89 CA1 (0.53) PTGS2PDK2PDK4CA12CA1
SCHEMBL17185517 0.80 CA1 (0.50) PTGS2CA12CA1CA2CA9
SCHEMBL17185515 0.80 CA1 (0.50) PTGS2CA12CA1CA2CA9
SCHEMBL24556302 0.78 PDK2 (0.40) PTGS2PDK2PDK4MEN1KMT2A
SCHEMBL9094147 0.76 ACVR1 (0.61) PTGS2CA12CA1CA2CA9
SCHEMBL14410532 0.72 PDK2 (0.55) PDK2PDK4MEN1KMT2AACVR1
SCHEMBL5893648 0.72 CA12 (0.69) CA12CA1CA2CA9MAOA
SCHEMBL5000802 0.71 CASP3 (0.47) CASP3CASP1CASP7CASP9
SCHEMBL29644955 0.71 CASP3 (0.47) CASP3CASP1CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11766439-B2 Human papilloma virus as predictor of cancer prognosis FOUNDATION MEDICINE, INC. (US) 2023-09-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11766439-B2 Human papilloma virus as predictor of cancer prognosis TP53, TSG101, EBNA1BP2 PTGS2 2229/4885PDK2 3001/4885PDK4 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback